CombiMatrix Corporation (CBMX) and Manhattan Labs Enter Strategic Partnership to Service NYC Metropolitan Area
8/13/2013 9:55:49 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
IRVINE, Calif., and NEW YORK, Aug. 13, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, and Manhattan Labs jointly announced today that they have entered into a strategic partnership under which Manhattan Labs will market and distribute CombiMatrix microarray tests for the miscarriage management testing market in the New York City metropolitan area. The partnership was enabled by the announcement in late June that CombiMatrix miscarriage management tests had received conditional approval from the New York State Department of Health for testing on patient samples within the state.
Help employers find you! Check out all the jobs and post your resume.
comments powered by